@vrs37 - you posted that "from what I can see their trial shares...

@vrs37 - you posted that "from what I can see their trial shares lot of similarity with dmx fgs phase 3 trial, like the same endpoints and length"

This is a very different view than that articulated in a recent Investor Presentation in a DXB announcement - where they claimed there is NO comparison with Travere's Duplex trial (see slide below).

I like contrary views that are based on science and logical argument, but I don't like manipulative innuendo.

While not, at this moment, accusing you of the latter, I would like to see your more detailed arguments as to why you are correct and why Dimerix management is not. Unsubstantiated statements or inferences are completely worthless!